Atlas Trials

A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age

Clinical trial NCT01165580 · COMPLETED

Trial details

NCT number
NCT01165580
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cytomegalovirus Infections, Heart Transplantation
Start date
2011-05-01
Primary completion
2013-09-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.